The Journal of Pediatrics
Volume 152, Issue 2 , Pages 160-164.e13 , February 2008

Defining the Metabolic Syndrome in Children and Adolescents: Will the Real Definition Please Stand Up?

  • Earl S. Ford, MD, MPH

      Affiliations

    • Corresponding Author InformationReprint requests: Earl Ford, MD, MPH, Centers for Disease Control and Prevention, 4770 Buford Highway, MS K66, Atlanta, GA 30341.
    • ,
  • Chaoyang Li, MD, PhD

Received 31 January 2007 ,Revised 5 June 2007 ,Accepted 3 July 2007.

References 

  1. Kylin E. Studien ueber das hypertonie-hypeglykämie-hyperurikämiesyndrom. Zentralblatt fuer Innere Medizin. 1923;44:105–127
  2. Reaven GM. Banting lecture 1988 (Role of insulin resistance in human disease). Diabetes. 1988;37:1595–1607
  3. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications (Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation). Diabet Med. 1998;15:539–553
  4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Geneva, Switzerland: World Health Organization; 1999;Report No.: WHO/NCD/NCS/99.2
  5. Balkau B, Charles MA. Comment on the provisional report from the WHO consultation (European Group for the Study of Insulin Resistance (EGIR)). Diabet Med. 1999;16:442–443
  6. Expert Panel on Detection EaToHBCiA. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497
  7. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735–2752
  8. Einhorn D, Reaven GM, Cobin RH, Ford E, Ganda OP, Handelsman Y, et al. American College of Endocrinology position statement on the insulin resistance syndrome. Endocrinol Pract. 2003;9:237–252
  9. Bloomgarden ZT. Definitions of the insulin resistance syndrome: the 1st World Congress on the Insulin Resistance Syndrome. Diabetes Care. 2004;27:824–830
  10. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. 2005. http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdfAccessed May 8, 2007
  11. Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V, et al. Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?. Diabetes. 1999;48:2422–2429
  12. Torok K, Szelenyi Z, Porszasz J, Molnar D. Low physical performance in obese adolescent boys with metabolic syndrome. Int J Obes Relat Metab Disord. 2001;25:966–970
  13. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988-1994. Arch Pediatr Adolesc Med. 2003;157:821–827
  14. Andersen LB, Wedderkopp N, Hansen HS, Cooper AR, Froberg K. Biological cardiovascular risk factors cluster in Danish children and adolescents: the European Youth Heart Study. Prev Med. 2003;37:363–367
  15. Cruz ML, Weigensberg MJ, Huang TT, Ball G, Shaibi GQ, Goran MI. The metabolic syndrome in overweight Hispanic youth and the role of insulin sensitivity. J Clin Endocrinol Metab. 2004;89:108–113
  16. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, et al. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004;350:2362–2374
  17. Lambert M, Paradis G, O’Loughlin J, Delvin EE, Hanley JA, Levy E. Insulin resistance syndrome in a representative sample of children and adolescents from Quebec, Canada. Int J Obes Relat Metab Disord. 2004;28:833–841
  18. Goodman E, Daniels SR, Morrison JA, Huang B, Dolan LM. Contrasting prevalence of and demographic disparities in the World Health Organization and National Cholesterol Education Program Adult Treatment Panel III definitions of metabolic syndrome among adolescents. J Pediatr. 2004;145:445–451
  19. de Ferranti SD, Gauvreau K, Ludwig DS, Neufeld EJ, Newburger JW, Rifai N. Prevalence of the metabolic syndrome in American adolescents: findings from the Third National Health and Nutrition Examination Survey. Circulation. 2004;110:2494–2497
  20. Rodriguez-Moran M, Salazar-Vazquez B, Violante R, Guerrero-Romero F. Metabolic syndrome among children and adolescents aged 10-18 years. Diabetes Care. 2004;27:2516–2517
  21. Papadopoulou-Alataki E, Papadopoulou-Legbelou K, Doukas L, Karatzidou K, Pavlitou-Tsiontsi A, Pagkalos E. Clinical and biochemical manifestations of syndrome X in obese children. Eur J Pediatr. 2004;163:573–579
  22. Ogawa Y, Kikuchi T, Nagasaki K, Hiura M, Tanaka Y, Uchiyama M. Usefulness of serum adiponectin level as a diagnostic marker of metabolic syndrome in obese Japanese children. Hypertens Res. 2005;28:51–57
  23. Viner RM, Segal TY, Lichtarowicz-Krynska E, Hindmarsh P. Prevalence of the insulin resistance syndrome in obesity. Arch Dis Child. 2005;90:10–14
  24. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics. 2005;115:e290–e296
  25. da Silva RC, Miranda WL, Chacra AR, Dib SA. Metabolic syndrome and insulin resistance in normal glucose tolerant Brazilian adolescents with family history of type 2 diabetes. Diabetes Care. 2005;28:716–718
  26. Yoshinaga M, Tanaka S, Shimago A, Sameshima K, Nishi J, Nomura Y, et al. Metabolic syndrome in overweight and obese Japanese children. Obes Res. 2005;13:1135–1140
  27. Park HS, Park JY, Cho SI. Familial aggregation of the metabolic syndrome in Korean families with adolescents. Atherosclerosis. 2006;186:215–221
  28. Vikram NK, Misra A, Pandey RM, Luthra K, Wasir JS, Dhingra V. Heterogeneous phenotypes of insulin resistance and its implications for defining metabolic syndrome in Asian Indian adolescents. Atherosclerosis. 2006;186:193–199
  29. Whincup PH, Gilg JA, Donald AE, Katterhorn M, Oliver C, Cook DG, et al. Arterial distensibility in adolescents: the influence of adiposity, the metabolic syndrome, and classic risk factors. Circulation. 2005;112:1789–1797
  30. Atabek ME, Pirgon O, Kurtoglu S. Prevalence of metabolic syndrome in obese Turkish children and adolescents. Diabetes Res Clin Pract. 2006;72:315–321
  31. Park HS, Han JH, Choi KM, Kim SM. Relation between elevated serum alanine aminotransferase and metabolic syndrome in Korean adolescents. Am J Clin Nutr. 2005;82:1046–1051
  32. Butte NF, Comuzzie AG, Cole SA, Mehta NR, Cai G, Tejero M, et al. Quantitative genetic analysis of the metabolic syndrome in Hispanic children. Pediatr Res. 2005;58:1243–1248
  33. Klein-Platat C, Drai J, Oujaa M, Schlienger JL, Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr. 2005;82:1178–1184
  34. Esmaillzadeh A, Mirmiran P, Azizi F. Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr. 2006;83:36–46
  35. Golley RK, Magarey AM, Steinbeck KS, Baur LA, Daniels LA. Comparison of metabolic syndrome prevalence using six different definitions in overweight pre-pubertal children enrolled in a weight management study. Int J Obes (Lond). 2006;30:853–860
  36. Gilardini L, McTernan PG, Girola A, da Silva NF, Alberti L, Kumar S, et al. Adiponectin is a candidate marker of metabolic syndrome in obese children and adolescents. Atherosclerosis. 2006;189:401–407
  37. Iannuzzi A, Licenziati MR, Acampora C, Renis M, Agrusta M, Romano L, et al. Carotid artery stiffness in obese children with the metabolic syndrome. Am J Cardiol. 2006;97:528–531
  38. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996;98:649–658
  39. Ravaja N, Keltikangas-Jarvinen L, Viikari J. Life changes, locus of control and metabolic syndrome precursors in adolescents and young adults: a three-year follow-up. Soc Sci Med. 1996;43:51–61
  40. Batey LS, Goff DC, Tortolero SR, Nichaman MZ, Chan W, Chan FA, et al. Summary measures of the insulin resistance syndrome are adverse among Mexican-American versus non-Hispanic white children: the Corpus Christi Child Heart Study. Circulation. 1997;96:4319–4325
  41. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667–674
  42. Dwyer T, Blizzard L, Venn A, Stankovich JM, Ponsonby AL, Morley R. Syndrome X in 8-y-old Australian children: stronger associations with current body fatness than with infant size or growth. Int J Obes Relat Metab Disord. 2002;26:1301–1309
  43. Moreno LA, Pineda I, Rodriguez G, Fleta J, Giner A, Juste MG, et al. Leptin and metabolic syndrome in obese and non-obese children. Horm Metab Res. 2002;34:394–399
  44. Schutte AE, van Rooyen JM, Huisman HW, Kruger HS, de Ridder JH. Factor analysis of possible risks for hypertension in a black South African population. J Hum Hypertens. 2003;17:339–348
  45. Park HS, Lee MS, Park JY. Leptin and the metabolic syndrome in Korean adolescents: factor analysis. Pediatr Int. 2004;46:697–703
  46. Goodman E, Dolan LM, Morrison JA, Daniels SR. Factor analysis of clustered cardiovascular risks in adolescence: obesity is the predominant correlate of risk among youth. Circulation. 2005;111:1970–1977
  47. Retnakaran R, Zinman B, Connelly PW, Harris SB, Hanley AJ. Nontraditional cardiovascular risk factors in pediatric metabolic syndrome. J Pediatr. 2006;148:176–182
  48. Li C, Ford ES. Is there a single underlying factor for the metabolic syndrome in adolescents? (A confirmatory factor analysis). Diabetes Care. 2007;Epub ahead of print
  49. Pladevall M, Singal B, Williams LK, Brotons C, Guyer H, Sadurni J, et al. A single factor underlies the metabolic syndrome: a confirmatory factor analysis. Diabetes Care. 2006;29:113–122
  50. Duncan GE, Li SM, Zhou XH. Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care. 2004;27:2438–2443
  51. Ford ES, Ajani UA, Mokdad AH. The metabolic syndrome and concentrations of C-reactive protein among U.S. youth. Diabetes Care. 2005;28:878–881
  52. Braunschweig CL, Gomez S, Liang H, Tomey K, Doerfler B, Wang Y, et al. Obesity and risk factors for the metabolic syndrome among low-income, urban, African American schoolchildren: the rule rather than the exception?. Am J Clin Nutr. 2005;81:970–975
  53. Weitzman M, Cook S, Auinger P, Florin TA, Daniels S, Nguyen M, et al. Tobacco smoke exposure is associated with the metabolic syndrome in adolescents. Circulation. 2005;112:862–869
  54. Coviello AD, Legro RS, Dunaif A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J Clin Endocrinol Metab. 2006;91:492–497
  55. Cruz ML, Goran MI. The metabolic syndrome in children and adolescents. Curr Diab Rep. 2004;4:53–62
  56. Steinbeck KS. Insulin resistance syndrome in children and adolescents: clinical meaning and indication for action. Int J Obes Relat Metab Disord. 2004;28:829–832
  57. Centers for Disease Control and Prevention. 2000 CDC Growth Charts for the United States: Methods and Development. Vital Health Statistics, Series 11. 2002;246:1–201
  58. Zannolli R, Morgese G. Waist percentiles: a simple test for atherogenic disease?. Acta Paediatr. 1996;85:1368–1369
  59. McCarthy HD, Jarrett KV, Crawley HF. The development of waist circumference percentiles in British children aged 5.0-16.9 y. Eur J Clin Nutr. 2001;55:902–907
  60. Fernandez JR, Redden DT, Pietrobelli A, Allison DB. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004;145:439–444
  61. Katzmarzyk PT. Waist circumference percentiles for Canadian youth 11-18y of age. Eur J Clin Nutr. 2004;58:1011–1015
  62. Fredriks AM, van BS, Fekkes M, Verloove-Vanhorick SP, Wit JM. Are age references for waist circumference, hip circumference and waist-hip ratio in Dutch children useful in clinical practice?. Eur J Pediatr. 2005;164:216–222
  63. Eisenmann JC. Waist circumference percentiles for 7- to 15-year-old Australian children. Acta Paediatr. 2005;94:1182–1185
  64. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004;114:555–576
  65. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2006;29(Suppl 1):S43-8.:S43-S48
  66. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: an epidemiologic perspective. Epidemiol Rev. 1998;20:157–172
  67. Meigs JB. Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol. 2000;152:908–911
  68. Lawlor DA, Ebrahim S, May M, Davey SG. (Mis)use of factor analysis in the study of insulin resistance syndrome. Am J Epidemiol. 2004;159:1013–1018
  69. Ford ES. Factor analysis and defining the metabolic syndrome. Ethn Dis. 2003;13:429–437
  70. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem. 2005;51:931–938
  71. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289–2304
  72. Grundy SM. Point: the metabolic syndrome still lives. Clin Chem. 2005;51:1352–1354
  73. Gale EA. The myth of the metabolic syndrome. Diabetologia. 2005;48:1679–1683
  74. Zimmet P, Magliano D, Matsuzawa Y, Alberti G, Shaw J. The metabolic syndrome: a global public health problem and a new definition. J Atheroscler Thromb. 2005;12:295–300

 The findings and conclusions in this article are those of the authors and do not represent the views of the Centers for Disease Control and Prevention.

PII: S0022-3476(07)00754-8

doi: 10.1016/j.jpeds.2007.07.056

The Journal of Pediatrics
Volume 152, Issue 2 , Pages 160-164.e13 , February 2008

Article Tools